News

Find News

Filter articles

Showing 51 to 60 of 2294 results

Pfizer teams up with Nektar in oncology deal

US07-11-2018

Pfizer has entered into an oncology collaboration with Nektar Therapeutics, a US development stage biopharma company.

German patent court publishes reasoning in Gilead SPC dispute

Germany06-11-2018

Germany’s Federal Patent Court has published the reasoning behind its decision to revoke Gilead Sciences’ supplementary protection certificate for HIV/AIDS treatment Truvada,

PhRMA shames Brazil and Thailand over patent backlogs

US06-11-2018

Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report. 

HGF hires former Roivant Sciences VP

Switzerland05-11-2018

HGF has strengthened its Basel, Switzerland office with the addition of Leena Contarino as a partner.

Cochlear ordered to pay $268m in patent clash

US05-11-2018

A US district court has ordered Australia-based Cochlear to pay $268 million in damages to the Alfred E Mann Foundation for Scientific Research and Advanced Bionics. 

Illumina buys rival Pacific Biosciences for $1.2bn

US02-11-2018

Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion. 

Gilead signs immuno-oncology deal with Tango

US02-11-2018

California-based Gilead Sciences has signed a collaboration agreement with Tango Therapeutics to discover and develop a pipeline of immuno-oncology treatments for cancer patients.

Former Genentech employees charged with trade secrets theft

US01-11-2018

Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft.

ERS Genomics licenses CRISPR patents to Cambridge University spin-out

EU, UK01-11-2018

The company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, ERS Genomics, has signed a patent licensing deal with DefiniGEN, a spin-out from the University of Cambridge, UK.

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

EU31-10-2018

Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Showing 51 to 60 of 2294 results

LSIPR